Sirona Biochem Corp V.SBM

Change of operational policy

[Transperance]

The 1067 clinical trial was financed by a third party and from earlier NR, I am sure it was stated that the clinical trial for 1326 would also be financed by a third party.

This statement from today’s NR comes as a nice surprise: “The clinical trial (for 1326) is fully financed, owned and controlled by Sirona.”

In my view, this sentence is the first really positive and potentially value-adding news in years.

Thus, there will be no third party right of first refusal. If results are favourable, it gives Sirona an opportunity to let multiple third parties compete in the bidding for the compound. With the assistance of Linda Pullan, I think Sirona will be able to succeed with that kind of bidding activity.

I am not selling any shares at this point of time.

[Transperance]

From the September Corporate Update, page 9, last paragraph • Sirona will aim to finalize our partnership discussions for a right of first refusal prior to the commencement of the trial.

[biorun]

So logic then says a first interest at table likely exists. Interesting times.

[navajojoe]

This post has been removed in accordance with Community Policy

[str8goods4achg]

I wouldn't expect the share price to move much from an informational NR. Glad to have this update though. If the trial shows positive results... then I would expect a positive reaction. GLTA

[moneycollector]

How does your "logic" come to this conclusion?

[biorun]

September presentation: "Sirona will aim to finalize our partnership discussions for a right of first refusal prior to the commencement of the trial." Who do you think they were in discussions with, themselves? Sounds like the idea of a first right of refusal is not in the cards because they are doing this on their own terms, as noted today.

[navajojoe]

This post has been removed in accordance with Community Policy

[moneycollector]

So either Sirona decided to go alone or this so called "first interest" left the table for some reasons. 

[biorun]

I think we should not worry our little bonnets here about  this. Having full control gives them numerous advantages when a deal is being negotiated. And if this generates lipid beneath the skin, then I would suspect that Abbvie, owner of Botox, might poke their nose around if for nothing more than continuing to control that space.

[LakeOromocto]

Yes and who do you think helped them set up the parameters for this trial?? AbbVie my guess!

[forhandlaren]

The best news in years. Not the start of the clinical trial, but conducted without a partner.  I was discourage by the former statement that they was looking for a partner, which would be risky business if the partner turned out to be AbbVie. The compound has potential to reduce the sales of Botox, therefore it would be much better to partner with a competitor, AbbVie could sign a deal and

[biorun]

Good points. I believe there was a previous reference that TFC-1326 was considered a companion to Botox which targets limited areas on the neck/face. Either way, I am certain there are a lot of husbands out there wishing there was a cheaper alternative to $4-8k annual botox treatments for their wives. And maybe a few men too.

[SironaInvestor]

I'm still 100% sure that you are working for Sirona or PRC. No words about all the disappointments in the past from you. Everything is always pretty nice for you. A promised Q&A will be probably taken place after the AGM so no chance again for all of us to raise the hand before.  Have you seen the Sedar filling about the new option Plan? Have you read that? Any guess what that mean?

[Shocker]

Anyone who sends near 200 post is a pumper/works for Sirona and last choice is PRC.  Accountability runs to all the people groups and most of Sirona. I have no clue how much the CEO, CFO, PRC and mangement or any new staff or advisor, They represent the shareprice without the ability to bring confidence Or is the confidence come from Biorun dont sell I am not sure what is worse by the first

[SironaInvestor]

And additionally, who will Sirona convince any institutionell Investors when they can't share any financial numbers? Again, the whole management needs to retire soon!!!! Pray to Geraldine that she will get a better commercial team soon!!

[biorun]

You crack me up. Dude, this is a microcap and merely a hobby to offer commentary, the ups and downs can be expected why again would I publicly criticize my own investment? Are you nuts? I was right about buying at 11 cents, and I suspect I will be even more right as we enter a new super cycle of interesting things potentially ahead of us. See, the longer you stick around, and use your brain, the

[SironaInvestor]

Absolutely no interest in the market!!! A nice Christmas gift would the retirement of Mr. Verrico because that would boost the share price. But a narcissistic and inexperienced CEO in combination will bring the share price much quicker to zero. I mean he is the biggest shareholder so why the hell he is not listening?? This company needs a fresh management with the ambitions to promote this company

[moneycollector]

Don't forget magical Dr. Bieber! 

[MirrorWorldMan]

A quick look at the AbbVie website lists the many small research based companies that they are currently partnering with, along with all the logos of those companies. Very impressive list. Guess who is absent from that chart?  Makes me think things may not be as far along as Howie is trumpeting. 

[str8goods4achg]

I agree with you @Transperance, I think this is a very smart and bold move for the same reasons you have stated. Makes me speculate that they have a lot of confidence in the expectation for positive results and the value of this molecule. Looking back at all the "this will be the year" moments... 2023 is shaping up to finally be that year: 1067 royalties kicking in, potential PET deal